When is photodynamic therapy recommended for Bowen's disease?

Bowen's disease is an early form of squamous cell carcinoma confined to the outer skin layer. Photodynamic therapy uses a medicine that makes abnormal cells respond to a particular light, helping target the visible lesion while limiting treatment to the skin surface. It may be discussed for thin lesions, broad patches, or sites where preserving appearance and function matters.

The clinician still needs to consider the lesion’s thickness, borders, site, symptoms, immune health, and whether invasion is suspected. A biopsy can help establish the diagnosis and guide treatment. Redness, burning, crusting, and temporary light sensitivity can occur during recovery.

Book a dermatology review for a persistent scaly patch or a confirmed diagnosis. Take any biopsy report and list medicines, especially those that cause light sensitivity. Avoid applying unapproved products to the area before treatment, and plan how you will shield treated skin from strong light as instructed.

Discuss photodynamic therapy alongside options such as a procedure to remove the lesion, freezing, or prescribed topical treatment. Ask how the clinician will judge response and whether a second treatment or a further biopsy could be needed.

Seek prompt review if a patch becomes thick, painful, tender, ulcerated, or repeatedly bleeds, because these changes need assessment for possible deeper disease. After therapy, report severe swelling, spreading redness, pus, fever, or pain that is not settling.

Has a biopsy confirmed Bowen's disease, and is there any sign of invasion? Is this patch thin enough for photodynamic therapy? What alternatives are reasonable for its location, and how will you monitor the area after treatment?